The interactive chart is unavailable. The financial history below remains available.
Loading stock chart…
Company financial history
Valuation settings
Historical valuation
Weekly price and annual fundamentals
Historical snapshot · prices are not live quotes.
YEAR-OVER-YEAR
Annual metric change
Change from the previous reported fiscal year
HISTORICAL EARNINGS MULTIPLES
P/E ratio history
P/E at every stored weekly price, using the latest annual EPS by fiscal-period end. Annual EPS is carried forward; this is not TTM or forward P/E. P/E history calculation and limitations.
Both charts use the same weekly price dates and synchronized time ranges. Each P/E point divides that week’s close by the most recent annual EPS at or before that date; it is not interpolated. Adjusted-close ratios are approximations; later filings and restatements make this retrospective. Reference lines are comparisons, not price targets.
P/E observations in the selected window
| Price date | EPS fiscal end | Basic P/E (×) | Diluted P/E (×) |
|---|
FREE HISTORICAL COMPANY DATA
Vertex Pharmaceuticals (VRTX) financial history
Nasdaq · USD · Health Care · CIK 0000875320
Biotechnology · Company classification source
- Annual coverage
- 2008-12-31–2025-12-31 (18 periods)
- Latest fiscal period
- 2025-12-31
- Prices through
- 2026-05-08 · historical, not live
- Available metrics
- Basic EPS, Diluted EPS, FCF/share
Financial snapshot built 2026-08-27. Current membership snapshot: 2026-10-08. Prices and available dividend yields use Stooq adjusted-close approximations.
Vertex Pharmaceuticals diluted EPS history
18 stored annual diluted-EPS observations cover fiscal periods ending 2008-12-31–2025-12-31. The latest stored diluted EPS is 15.32 USD for the period ending 2025-12-31. View filing (2026-02-13)
Read the complete annual table or select Diluted EPS in the chart above. Learn to compare price with earnings.
Vertex Pharmaceuticals free cash flow per share history
18 stored annual FCF/share observations cover fiscal periods ending 2008-12-31–2025-12-31. The latest stored free cash flow per share is 12.38 USD for the period ending 2025-12-31. Operating cash flow (2026-02-13) · Capex (2026-02-13)
FCF/share is derived from operating cash flow minus capital expenditure, divided by matching annual diluted weighted-average shares. Select FCF / share in the chart above to explore it. Compare EPS and FCF per share.
Charts and CSV/PNG exports are free, without signup. Download and read the chart CSV. The export follows the selected chart window and metric; the annual table below retains the full stored history.
Tables and factual summaries are generated automatically from the stored snapshot. Maintained by Cheng. Sources & limitations.
VRTX annual financial history
All stored annual observations, independent of the chart window. Per-share amounts in USD. Unavailable values are not zero.
Dividend yields marked Approx. use Stooq adjusted closes. See the calculation and limitations.
Vertex Pharmaceuticals (VRTX) P/E ratio history
The interactive P/E chart contains all 1107 stored weekly price points (2005-02-25–2026-05-08); 436 have an eligible basic or diluted ratio. Annual EPS is carried forward from its fiscal end. Use the P/E range bar or the valuation range bar to change both chart windows.
Fiscal-year-end snapshots
9 eligible fiscal-year-end observations span 2011-12-31–2025-12-31. Latest eligible diluted P/E: 30.22×; basic P/E: 29.94×, for fiscal end 2025-12-31, using the close on 2025-12-26.
Annual P/E = eligible fiscal-year-end close ÷ reported annual EPS. Adjusted-close ratios are approximate. This is retrospective annual P/E, not TTM or forward P/E. Missing or non-positive EPS and missing eligible prices produce unavailable ratios.
Explore the P/E chart and optional reference lines · How P/E history is calculated.
Complete annual P/E history (18 fiscal periods)
| Fiscal end | Price date | Close | Price basis | Basic P/E | Diluted P/E | EPS filings |
|---|---|---|---|---|---|---|
| 2025-12-31 | 2025-12-26 | 462.90 | Adjusted close · Approx. | 29.94 | 30.22 | Basic EPS (2026-02-13) Diluted EPS (2026-02-13) |
| 2024-12-31 | 2024-12-27 | 408.76 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2026-02-13) Diluted EPS (2026-02-13) |
| 2023-12-31 | 2023-12-29 | 406.89 | Adjusted close · Approx. | 28.96 | 29.29 | Basic EPS (2026-02-13) Diluted EPS (2026-02-13) |
| 2022-12-31 | 2022-12-30 | 288.78 | Adjusted close · Approx. | 22.27 | 22.53 | Basic EPS (2025-02-13) Diluted EPS (2025-02-13) |
| 2021-12-31 | 2021-12-31 | 219.60 | Adjusted close · Approx. | 24.16 | 24.37 | Basic EPS (2024-02-15) Diluted EPS (2024-02-15) |
| 2020-12-31 | 2020-12-31 | 236.34 | Adjusted close · Approx. | 22.64 | 22.97 | Basic EPS (2023-02-10) Diluted EPS (2023-02-10) |
| 2019-12-31 | 2019-12-27 | 220.97 | Adjusted close · Approx. | 48.25 | 49.00 | Basic EPS (2022-02-09) Diluted EPS (2022-02-09) |
| 2018-12-31 | 2018-12-28 | 161.42 | Adjusted close · Approx. | 19.59 | 19.95 | Basic EPS (2021-02-11) Diluted EPS (2021-02-11) |
| 2017-12-31 | 2017-12-29 | 149.86 | Adjusted close · Approx. | 141.38 | 144.10 | Basic EPS (2020-02-13) Diluted EPS (2020-02-13) |
| 2016-12-31 | 2016-12-30 | 73.67 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2019-02-13) Diluted EPS (2019-02-13) |
| 2015-12-31 | 2015-12-31 | 125.83 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2018-02-15) Diluted EPS (2018-02-15) |
| 2014-12-31 | 2014-12-26 | 118.41 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2017-02-23) Diluted EPS (2017-02-23) |
| 2013-12-31 | 2013-12-27 | 73.45 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2016-02-16) Diluted EPS (2016-02-16) |
| 2012-12-31 | 2012-12-28 | 40.94 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2015-02-13) Diluted EPS (2015-02-13) |
| 2011-12-31 | 2011-12-30 | 33.21 | Adjusted close · Approx. | 237.21 | 237.21 | Basic EPS (2014-02-11) Diluted EPS (2014-02-11) |
| 2010-12-31 | 2010-12-31 | 35.03 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2013-03-01) Diluted EPS (2013-03-01) |
| 2009-12-31 | 2009-12-31 | 42.85 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2012-02-22) Diluted EPS (2012-02-22) |
| 2008-12-31 | 2008-12-26 | 29.50 | Adjusted close · Approx. | Unavailable | Unavailable | Basic EPS (2011-02-17) Diluted EPS (2011-02-17) |
WHY USE STOCK VALUE LENS
Free historical stock charts, P/E history and financial data
Explore weekly P/E ratio history using annual EPS and compare earnings and cash flow per share with historical stock prices, with clear coverage and source links.
- P/E ratio history using annual EPS
- Free approximate P/E at every stored weekly price, using basic or diluted annual EPS carried forward from fiscal end. Includes a synchronized P/E range bar and optional 15× / 20× / 30× references. Missing and non-positive EPS leave gaps. Retrospective, not TTM or forward P/E.
- Free, including exports
- All current charts and CSV/PNG exports are free. No account or subscription required.
- Long annual histories
- VRTX: 18 annual diluted EPS observations (2008-12-31–2025-12-31); 18 annual FCF/share observations (2008-12-31–2025-12-31). Coverage varies by metric; histories may have gaps.
- Historical weekly prices
- VRTX: weekly price observations from 2005-02-25 through 2026-05-08. Prices are historical, not live quotes.
- Filing-linked financial data
- EPS facts link to SEC filings. FCF/share is derived from reported cash-flow inputs and diluted shares. Historical prices come from Stooq.
Financial database built 2026-08-27. FCF/share is a derived measure; adjusted prices and associated dividend yields are labeled approximations. The formula line is a retrospective reference, not an intrinsic-value estimate. Verify sources, dates and limitations.
Browse the S&P 500 company directory or search 6,551 US-listed securities. Metric coverage varies.